GlassScriptPhysician profile
Melchor Z Jacob
NPI 1194962605
$23,408.34
in general payments reported to CMS, 2019-2025
52 companies · $5,718 in 2025
The $5,718 reported for 2025 was more than what 99% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,497 · 2022: $5,215 · 2023: $4,690 · 2024: $5,288 · 2025: $5,718.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $16K · Education: $9.20.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15,687.06 |
| Education | $9.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $3,793.86 | 2021-2025 | Repatha, Evenity, Otezla |
| Astrazeneca Pharmaceuticals LP | $2,811.28 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $2,753.59 | 2021-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Abbvie INC. | $1,521.83 | 2021-2025 | |
| Novo Nordisk INC | $1,290.44 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $1,179.93 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Bayer Healthcare Pharmaceuticals INC. | $1,131.14 | 2021-2025 | |
| Otsuka America Pharmaceutical, INC. | $1,127.34 | 2021-2025 | Rexulti |
| Daiichi Sankyo INC. | $706.01 | 2022-2025 | Injectafer |
| Merck Sharp & Dohme LLC | $577.93 | 2021-2025 | Verquvo, Belsomra, Steglatro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $568.26 | 2021-2025 | Jardiance, Tradjenta |
| Pfizer INC. | $513.37 | 2022-2025 | |
| Radius Health, INC. | $474.11 | 2021-2025 | Tymlos |
| Novartis Pharmaceuticals Corporation | $437.50 | 2022-2025 | |
| Horizon Therapeutics Plc | $355.06 | 2022-2023 | Krystexxa |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $343.19 | 2022-2024 | Senza |
| Corcept Therapeutics | $319.87 | 2022-2025 | Korlym |
| Axsome Therapeutics, INC. | $250.00 | 2024-2025 | Auvelity |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $238.50 | 2021-2025 | Xifaxan |
| Genzyme Corporation | $229.76 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $209.36 | 2021-2025 | Camzyos |
| Heartflow, INC. | $190.76 | 2025 | |
| Verona Pharma, INC. | $164.88 | 2025 | Ohtuvayre |
| Phathom Pharmaceuticals, INC. | $154.76 | 2024-2025 | Voquezna |
| Baxter Healthcare | $142.22 | 2023-2024 | Hillrom - Life 2000 Ventilation System, Hillrom - Monarch Airway Clearance System |
| Recordati_rare_diseases_inc. | $132.89 | 2025 | Isturisa |
| Janssen Pharmaceuticals, INC | $132.02 | 2021-2024 | Xarelto |
| Celgene Corporation | $125.00 | 2021 | |
| Shield Therapeutics INC | $124.05 | 2023-2025 | Accrufer |
| Electromed, INC. | $123.88 | 2022-2025 | Smartvest |
| Incyte Corporation | $114.91 | 2021 | |
| Philips North America LLC | $109.65 | 2021-2023 | |
| Organogenesis INC. | $104.01 | 2024 | Puraply Wound Matrix |
| Medtronic, INC. | $101.64 | 2023 | Contour 3d, Intellis Adaptivestim |
| Dexcom, INC. | $101.12 | 2021-2024 | Dexcom G6 Transmitter |
| Si-Bone, INC. | $100.63 | 2022 | |
| Abbott Laboratories | $94.80 | 2023 | Cardiomems |
| Biohaven Pharmaceutical Holding Company LTD. | $78.59 | 2022 | |
| Aurinia Pharma U.S., INC. | $71.98 | 2024 | Lupkynis |
| Depuy Synthes Sales INC. | $57.63 | 2025 | Trufill |
| Esperion Therapeutics, INC. | $55.39 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $48.88 | 2025 | |
| Lundbeck LLC | $43.23 | 2025 | Rexulti |
| Biosense Webster, INC. | $33.15 | 2023 | Qdot Micro Catheter |
| Abiomed | $32.35 | 2025 | |
| Emd Serono, INC. | $26.82 | 2022 | |
| Idorsia Pharmaceuticals US INC | $20.67 | 2023 | Quviviq |
| Advanced Respiratory, INC | $19.54 | 2021 | |
| Amarin Pharma, INC. | $19.14 | 2021 | |
| Eisai INC. | $18.28 | 2025 | |
| Exact Sciences Corporation | $16.67 | 2025 | The Cologuard Plus Collection Kit |
| Ultragenyx Pharmaceutical INC. | $16.47 | 2025 | Dojolvi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melchor Jacob listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.